Skip to main content
Microorganisms logoLink to Microorganisms
. 2021 Apr 28;9(5):950. doi: 10.3390/microorganisms9050950

A Case of Atypical Bartonellosis in a 4-Year-Old Immunocompetent Child

Chiara Sodini 1, Elena Mariotti Zani 1, Francesco Pecora 1, Cristiano Conte 1, Viviana Dora Patianna 1, Giovanni Prezioso 1, Nicola Principi 2, Susanna Esposito 1,*
Editor: Arto Pulliainen
PMCID: PMC8146596  PMID: 33924906

Abstract

In most cases, infection due to Bartonella henselae causes a mild disease presenting with a regional lymphadenopathy frequently associated with a low-grade fever, headache, poor appetite and exhaustion that spontaneously resolves itself in a few weeks. As the infection is generally transmitted by cats through scratching or biting, the disease is named cat scratch disease (CSD). However, in 5–20% of cases, mainly in immunocompromised patients, systemic involvement can occur and CSD may result in major illness. This report describes a case of systemic CSD diagnosed in an immunocompetent 4-year-old child that can be used as an example of the problems that pediatricians must solve to reach a diagnosis of atypical CSD. Despite the child’s lack of history suggesting any contact with cats and the absence of regional lymphadenopathy, the presence of a high fever, deterioration of their general condition, increased inflammatory biomarkers, hepatosplenic lesions (i.e., multiple abscesses), pericardial effusion with mild mitral valve regurgitation and a mild dilatation of the proximal and medial portion of the right coronary artery, seroconversion for B. henselae (IgG 1:256) supported the diagnosis of atypical CSD. Administration of oral azithromycin was initiated (10 mg/kg/die for 3 days) with a progressive normalization of clinical, laboratory and US hepatosplenic and cardiac findings. This case shows that the diagnosis of atypical CSD is challenging. The nonspecific, composite and variable clinical features of this disease require a careful evaluation in order to achieve a precise diagnosis and to avoid both a delayed diagnosis and therapy with a risk of negative evolution.

Keywords: atypical bartonellosis, Bartonella henselae, bartonellosis, cat scratch disease, hepatosplenic abscesses

1. Background

In most cases, infection due to Bartonella henselae causes a mild disease presenting with a regional lymphadenopathy frequently associated with a low-grade fever, headache, poor appetite and exhaustion that spontaneously resolves itself in a few weeks [1]. As infection is generally transmitted by cats through scratching or biting [2], the disease is named cat scratch disease (CSD). However, in 5–20% of cases, mainly in immunocompromised patients, systemic involvement can occur and CSD may result in major illness [3]. A prolonged high fever can develop and be associated with a number of severe clinical manifestations. Skin, eyes, liver, spleen, heart and nervous and musculoskeletal systems can be involved. In these cases, prompt diagnosis and proper treatment are mandatory to avoid immediate and serious long-term risks for the patient [3]. Unfortunately, due to the variability of signs and symptoms and the lack of gold standard criteria, a diagnosis of systemic CSD can be both difficult and significantly delayed. Atypical CSD can evolve completely uncontrolled for several days [4]. For a rapid diagnosis, a high index of suspicion is needed: clinical features and compatible epidemiological context should be accurately evaluated, the most reliable laboratory tests should be performed and results must be rationally evaluated.

This report describes a case of systemic CSD diagnosed in an immunocompetent child that can be used as an example of the problems that pediatricians must solve to reach a diagnosis of atypical CSD.

2. Case Presentation

A 4-year-old boy with unremarkable medical history was admitted to the hospital due to a 5-day intermittent fever peaking up to 41 °C and associated with abdominal pain. In the period preceding hospitalization, the child had received only paracetamol when their body temperature was above 38.5 °C. Moreover, although in close contact with pets, family members did not recall the child having been scratched or bitten. No bites by fleas, keds, lice, sand flies, ticks, mites or spiders were reported.

At admission, the physical examination revealed an axillary temperature of 39.9 °C, a blood pressure of 90/60 mm Hg, a heart rate of 96 beats per minute and a respiratory rate of 18 breaths per minute. A slight bilateral cervical lymphadenopathy was noted. No skin lesion ascribable to cat scratches or bites was detectable on any exposed surface. The chest and abdomen examination did not result in any pathological finding. The liver edge was palpable at the right costal margin. The spleen was not palpable. Laboratory tests showed a normal and complete blood count (Hb 12.8 g/dL, white blood cells 9350/mm3, neutrophils 46.5%, platelets 217,000/mm3), but there was a significant increase in serum acute phase reactants values (C-reactive protein (CRP) 56.6 mg/L, procalcitonin (PCT) 13.84 ng/mL). Serum aspartate aminotransferase and alanine aminotransferase showed an increase (101 U/L and 107 U/L, respectively), whereas the results of all the other laboratory tests including proteinogram, complement fraction, coagulation markers and α-fetoprotein were within the normal range (Table 1). Eye examination was normal. Chest X-ray did not show any abnormalities, but the lung ultrasound (US) revealed a slight bilateral pleural effusion; echocardiography was normal. The abdomen ultrasound revealed slight hepatosplenomegaly, enlarged hilum-hepatic lymph nodes, acalculous cholecystitis and the presence of pericholecystic fluid.

Table 1.

Laboratory findings on admission and during follow-up in a 4-year-old immunocompetent child with atypical bartonellosis.

Variable On Admission Time from Admission 15 Days after Discharge
Day
3
Day
5
Day
10
Day
16
Day
20
Day
24
Hemoglobin (g/dL) 12.8 10.5 10 11.1 11.5 11.0 11.7 11.8
Hematocrit (%) 37.6 32 30 34.3 35.2 34 36.5 35.6
White cell count (per μL) 9350 7770 9860 8920 5140 6330 6870 6370
Neutrophils (%) 46.5 42.3 59.3 25.7 26 21.2 18.6 21.6
Limphocytes (%) 44.1 47.7 29.5 56.6 53.5 59.6 68.3 66.1
Monocytes (%) 3.8 9.5 10.8 14.3 11.8 15 8.4 9.3
Eosinophils (%) 0.1 0.0 0.1 3.0 3.1 3.3 4.1 2.7
Basophils (%) 0.7 0.5 0.3 0.4 1.3 0.9 0.6 0.3
Red-cell count (per μL) 4.75 × 106 3.98 × 106 3.78 × 106 4.26 × 106 4.37 × 106 4.27 × 106 4.65 × 106 4.62 × 106
Platelet count (per μL) 217,000 200,000 328,000 587,000 540,000 483,000 521,000 398,000
Sodium (mEq/L) 131 134 - 135 133 132 136 137
Potassium (mEq/L) 4 4.2 - 4.6 5.1 5.1 4.8 4.3
Chloride (mEq/L) 99 106 - 102 101 100 102 103
Calcium (mg/dL) 9.0 8.0 - 9.0 9.2 9.6 10.2 9.8
Urea nitrogen (mg/dL) 29 12 - 26 41 41 30 38
Creatinine (mg/dL) 0.5 0.3 - 0.4 0.3 0.3 0.2 0.4
Glucose (mg/dL) 105 103 - 120 75 86 80 84
Albumin (g/dL) - 3.0 - 3.3 3.7 3.9 4.8
ALT (U/L) 101 70 - 36 28 47 39 23
AST (U/L) 107 62 - 21 50 64 58 45
CRP (mg/L) 57.6 47.5 65.9 - 11.2 - 1.2 0.5
PCT (ng/mL) 13.84 10.38 3.64 - - - 0.06 0.02
ESR (mm/hr) - 95 - - 86 - - 36

ALT, alanine aminotransferase; AST, aspartate aminotransferase; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; PCT, procalcitonin.

Extensive laboratory tests to exclude infections and lymphoproliferative disorders were performed. In particular, a Mantoux test and interferon-gamma release assay (IGRA) for tuberculosis and serologic testing for B. henselae, cytomegalovirus, Toxoplasma gondii, Mycoplasma pneumoniae, Epstein–Barr virus, adenovirus, HCV, enterovirus, Shigella, Yersinia, Salmonella typhi, Brucella and Coxiella burnetii infections were performed. A blood sample for bacterial culture was collected. While awaiting results, an empiric intravenous antibiotic therapy with piperacillin–tazobactam (150 mg/kg/die in three doses) was started.

On the third day of hospitalization, with all laboratory tests specifically planned to identify infectious agents receiving negative results, persistence of a fever up to 39 °C in the early morning and afternoon and a slight but substantial deterioration of the child’s general conditions, we repeated both blood tests and the US. Results showed mild hypoalbuminemia and hyponatremia, with a persistent high level of CRP and PCT, and an elevated erythrocyte sedimentation rate (Table 1). The abdominal US showed the onset of multiple hypoechoic liver and spleen lesions with a target appearance and irregular margins (Figure 1), suggesting multiple hepatosplenic abscesses. Moreover, the presence of fluid in abdominal recesses was evidenced. A second echocardiography showed the appearance of pericardial effusion, mild mitral valve regurgitation and a mild dilatation of the proximal and medial portion of the right coronary artery (respectively, Z-score +2.53 and +2.31), with a normal value of the myocardial contractility (75%). Piperacillin–tazobactam was discontinued and a combined antibiotic therapy with intravenous meropenem (100 mg/kg/die in three doses) and intravenous vancomycin (40 mg/kg/die in three doses) was started. Screening for B. henselae was repeated, this time with positive results (IgG 1:256).

Figure 1.

Figure 1

Liver and spleen ultrasound scans of the patient on admission (AC) and during follow-up (D,E) in a 4-year-old immunocompetent child with atypical bartonellosis. Admission. (A,B): enlarged inhomogeneous spleen with multiple hypoechoic lesions (A): ∅ 15 mm; (B): ∅ 17 mm). (C): liver appears of increased echogenicity, with multiple hypoechoic lesions; the arrow indicates the larger one (∅ 15 mm) in hepatic segment V. Enlargement of hilar hepatic lymphnodes can be appreciated. After one month from admission. (D,E): abdominal ultrasound shows the disappearance of the hepatic lesions (D) and the persistence of two hypoechoic spleen lesions, in decline (E): largest lesion, ∅ 7 mm, previously ∅ 17 mm as shown in (B).

Despite the lack of history suggesting contact with cats, due to the presence of hepatosplenic lesions (i.e., multiple abscesses) in the absence of any different potential etiology, the diagnosis of atypical CSD was considered highly likely and administration of oral azithromycin was initiated (10 mg/kg/die for 3 days). Clinical, laboratory and US hepatosplenic and cardiac findings progressively normalized. The repetition of the B. henselae antibody after one month confirmed the titer detected during the hospitalization (IgG 1:256) and the last abdominal US revealed the disappearance of the hypoechoic liver lesions and the persistence of two hypoechoic spleen lesions, which were in decline.

3. Discussion

The case reported here highlights how difficult the diagnosis of atypical CSD can be and how only a high index of suspicion can allow the prescription of an effective therapy in a short time period. Understanding the complex interactions between B. henselae, its vectors and its reservoirs, as well as the breadth of infection by B. henselae around the world, will help to assess the impact of bartonellosis on public health [5]. In addition to transmission through domestic animals, numerous different vectors transmit Bartonella species. These vectors include fleas, keds, lice, sand flies and potentially ticks, mites and spiders [5]. Atypical CSD is relatively uncommon in younger children and this can be, per se, a limit to suspect the disease, particularly, as in this case, when no significant lymphadenopathy is present. In the USA, among the 224 cases described between 2005 and 2014, only 36.2% were diagnosed in children <14 years of age [3]. Moreover, gold standard criteria for a definitive diagnosis have not been established. An attempt was made some years ago by Margileth [6], who suggested that a definitive diagnosis could be made if, in a patient, the following four criteria could be satisfied: (1) cat or flea contact with or without a scratch mark or a regional inoculation lesion; (2) negative tests for other potential causes of adenopathy or infection, including polymerase chain reaction (PCR) tests on blood or tissue samples and computed tomography scans of liver and spleen; (3) a positive enzyme immunoassay (EIA) or indirect fluorescent antibody assay serology test > 1:64 for B. henselae; (4) a biopsy of a lymph node, skin, liver, bone or eye showing granulomatous inflammation compatible with CSD. However, considering the patient history, reliability of laboratory tests and difficulties in performing biopsies, it seems highly unlikely that all these criteria can be simultaneously satisfied in a patient. Even if contact with a cat is common, skin lesions due to scratches or bites are detected in only 60% of documented CSD cases [7]. Moreover, poor attention is generally paid to the potential role of dogs in B. henselae infection transmission as these pets have been found implicated in approximately 5% of cases [8]. Serologic tests, such as both EIAs and indirect immunofluorescence assays, have suboptimal sensitivity and specificity and can lead to incorrect results in a relevant number of cases [9]. The low specificity is ascribed to the high seroprevalence in the normal population due to cross reactivity with Coxiella burnetii infection, Chlamydophila infection and non-henselae Bartonella infections [10,11]. The low sensitivity appears to be strictly associated with the distribution of different B. henselae genotypes. Serologic tests are more effective in the detection of antibodies against genotype 1, and, if genotype 2 is the cause of disease, tests can be negative despite a true infection [9]. Moreover, a prior infection can cause false positive results. Limitations can also derive from the use of PCR tests to detect B. henselae in blood or in tissue biopsies. Despite the fact that reliable results of DNA amplification methods for the identification of B. henselae have been reported [12], in the same cases of atypical CSD recently described, PCR tests were repeatedly found unable to detect the pathogen [13]. Finally, the authorization to perform biopsies for histological assessments may be delayed or even denied by the parents of children with a supposed infection.

In the case described here, all the criteria proposed by Margileth could not be satisfied [6]. Diagnosis was suspected starting from the splenic and liver US findings, the evidence that most of the infectious diseases with clinical manifestation resembling CSD could be excluded and the lack of response to broad-spectrum antibiotic therapy. Hepatosplenic involvement occurs in around one quarter of atypical CSD cases with children <14 years of age at increased risk (relative risk (RR) 1.76, 95% confidence interval (CI) 1.04–2.99) [6]. When present, micro-abscesses are considered as evidence of atypical CSD, particularly when patients have persistent fever, abdominal pain and characteristic abdominal US findings, as in the patient here reported. The evidence of a positive EIA test was later considered a further element for diagnosis as it was the temporal association between the administration of azithromycin and the prompt resolution of clinical manifestations.

In this case, together with hepatosplenic lesions, significant cardiac involvement was found. This is relatively uncommon and once again highlights the difficulties for a proper diagnosis of atypical CSD. In the aforementioned USA study, only 3.6% of cases presented with cardiac signs and symptoms [3]. Endocarditis is the most common cardiac diagnosis. It is described more frequently in adults, though a previous valvular disease can favor this complication in children [14]. However, other heart manifestations have been associated as part of the clinical picture of atypical CSD. Myocarditis and pericarditis have been described [15]. Moreover, as B. henselae has been found able to infect endothelial cells and reduce their number and functionality, it has been supposed that this pathogen could play a role in the determination of acute and long-term vascular alterations [16].

Finally, in this child, a strict temporal relationship between the use of azithromycin and disease resolution was found. The real importance of the prescribed antibiotic treatment for the resolution of this case could be debated, as the efficacy of antibiotics in atypical CSD cases is not precisely defined and official recommendations are lacking. Suggestions for antibiotic treatment are usually based only on personal experience and expert opinion [16]. However, the rapid improvement of all clinical manifestations of the disease, including the most severe ones, such as hepatic and splenic micro-abscesses, seems to indicate a possible direct effect of the antibiotic therapy. Regarding antibiotic use, despite the fact that these drugs are not recommended in mild to moderate typical CSD cases, their administration is suggested in atypical cases, particularly when they occur in immunocompromised subjects. A group of drugs including macrolides, rifampin, ciprofloxacin, trimethoprim–sulfamethoxazole and gentamicin are considered of choice [17,18,19,20]. Other antibiotics, including those initially prescribed in the reported patient, are not recommended as, despite being effective in vitro, they were not effective in vivo in typical CSD cases [21]. Unfortunately, the dosages and duration of treatment are not established. In addition, new light was shed on the treatment of bartonellosis owing to a recent publication that showed a non-coding RNA that controlled the transcription of a gene encoding a DNA-binding protein that modulates biofilm development in B. henselae [22].

4. Conclusions

This case shows that the diagnosis of atypical CSD is challenging. The nonspecific, composite and variable clinical features of this disease require a careful evaluation in order to achieve a precise diagnosis and avoid both a delayed diagnosis and a risk of negative evolution. In the case of a prolonged fever of unknown origin, when abdominal pain, hepatosplenic lesions on US and heart abnormalities are present, a B. henselae infection must be considered even if a suggestive history or a clear lymphadenopathy is lacking. In these cases, antibiotic treatment with drugs considered effective against B. henselae must be prescribed.

Acknowledgments

We would like to thank Francesco Sogni, Lara Abelli, Umberto Fanelli and Rosanna Iannarella, Lorenzo Bertolini and Simone Cella for their support in the patient’s management.

Author Contributions

C.S. and E.M.Z. wrote the first draft of the manuscript. F.P. and C.C. performed the literature review and supported the patient’s management. V.D.P. and G.P. were in charge of the patient’s management and follow-up. N.P. provided scientific contributions and critically revised the paper. S.E. supervised the patient’s management and follow-up as well as the preparation of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Area Vasta Emilia Romagna Nord (PED-2021-02).

Informed Consent Statement

Written informed consent for patient’s management and for the publication of this Case report was obtained from the parents of the child involved in the study.

Data Availability Statement

All the available data were reported in the Case presentation.

Conflicts of Interest

The authors declare no conflict of interest.

Ethics Statement

This case report was approved by the Ethics Committee of Area Vasta Emilia Romagna Nord (PED-2021-02), and both parents provided written informed consent for the evaluation of the child.

Consent to Publish Statement

The Ethics Committee of Area Vasta Emilia Romagna Nord approved the publication of this case report, and both parents provided written informed consent for the publication of this manuscript.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Arıcı N., Aksaray S., Ankaralı H. Bartonella henselae IgM seropositivity in both adult and pediatric patients with diverse clinical conditions in Turkey. Acta Microbiol. Immunol. Hung. 2021 doi: 10.1556/030.2021.01310. [DOI] [PubMed] [Google Scholar]
  • 2.Chomel B.B., Boulouis H.-J., Maruyama S., Breitschwerdt E.B. Bartonella Spp. in Pets and Effect on Human Health. Emerg. Infect. Dis. 2006;12:389–394. doi: 10.3201/eid1203.050931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nawrocki C.C., Max R.J., Marzec N.S., Nelson C.A. Atypical Manifestations of Cat-Scratch Disease, United States, 2005–2014. Emerg. Infect. Dis. 2020;26:1438–1446. doi: 10.3201/eid2607.200034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lemos A.P., Domingues R., Gouveia C., De Sousa R., Brito M.J. Atypical bartonellosis in children: What do we know? J. Paediatr. Child Health. 2020 doi: 10.1111/jpc.15304. [DOI] [PubMed] [Google Scholar]
  • 5.Cheslock M.A., Embers M.E. Human Bartonellosis: An Underappreciated Public Health Problem? Trop. Med. Infect. Dis. 2019;4:69. doi: 10.3390/tropicalmed4020069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Margileth A.M. Recent advances in diagnosis and treatment of cat scratch disease. Curr. Infect. Dis. Rep. 2000;2:141–146. doi: 10.1007/s11908-000-0026-8. [DOI] [PubMed] [Google Scholar]
  • 7.Uluğ M. Evaluation of Cat Scratch Disease Cases Reported from Turkey between 1996 and 2013 and Review of the Literature. Cent. Eur. J. Public Health. 2015;23:170–175. doi: 10.21101/cejph.a4040. [DOI] [PubMed] [Google Scholar]
  • 8.Zobba R., Chessa G., Mastrandrea S., Parpaglia M.L.P., Patta C., Masala G. Serological and molecular detection of Bartonella spp. in humans, cats and dogs from northern Sardinia, Italy. Clin. Microbiol. Infect. 2009;15:134–135. doi: 10.1111/j.1469-0691.2008.02203.x. [DOI] [PubMed] [Google Scholar]
  • 9.Vermeulen M.J., Herremans M., Verbakel H., Bergmans A.M., Roord J.J., van Dijken P.J., Peeters M.F. Serological testing for Bartonella hen-selae infections in The Netherlands: Clinical evaluation of immunofluorescence assay and ELISA. Clin. Microbiol. Infect. 2007;13:627–634. doi: 10.1111/j.1469-0691.2007.01700.x. [DOI] [PubMed] [Google Scholar]
  • 10.Sander A., Berner R., Ruess M. Serodiagnosis of cat scratch disease: Response to Bartonella henselae in children and a review of diagnostic methods. Eur. J. Clin. Microbiol. Infect. Dis. 2001;20:392–401. doi: 10.1007/PL00011280. [DOI] [PubMed] [Google Scholar]
  • 11.Vermeulen M.J., Verbakel H., Notermans D., Reimerink J., Peeters M. Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology. J. Med. Microbiol. 2010;59:743–745. doi: 10.1099/jmm.0.015248-0. [DOI] [PubMed] [Google Scholar]
  • 12.Allizond V., Costa C., Sidoti F., Scutera S., Bianco G., Sparti R., Banche G., Dalmasso P., Cuffini A.M., Cavallo R., et al. Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: A comparative study. PLoS ONE. 2019;14:e0211945. doi: 10.1371/journal.pone.0211945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sarno M., Rosanio F.M., De Brasi D., Santoro C., Lo Vecchio A., Esposito F. Systemic cat-scratch disease: A “Troublesome” diagnosis. Pediatr. Infect. Dis. J. 2021;40:e117–e119. doi: 10.1097/INF.0000000000002996. [DOI] [PubMed] [Google Scholar]
  • 14.Florin T.A., Zaoutis T.E., Zaoutis L.B. Beyond Cat Scratch Disease: Widening Spectrum of Bartonella henselae Infection. Pediatrics. 2008;121:e1413–e1425. doi: 10.1542/peds.2007-1897. [DOI] [PubMed] [Google Scholar]
  • 15.Barson W.J., Honegger J.R., Texter K. Acute Myopericarditis Associated with Cat Scratch Disease in an Adolescent. Pediatr. Infect. Dis. J. 2014;33:982–984. doi: 10.1097/INF.0000000000000352. [DOI] [PubMed] [Google Scholar]
  • 16.Salvatore P., Zullo A., Sommese L., Colicchio R., Picascia A., Schiano C., Mancini F.P., Napoli C. Infections and cardiovascular disease: Is Bartonella henselae contributing to this matter? J. Med. Microbiol. 2015;64:799–809. doi: 10.1099/jmm.0.000099. [DOI] [PubMed] [Google Scholar]
  • 17.Rolain J.M., Brouqui P., Koehler J.E., Maguina C., Dolan M.J., Raoult D. Recommendations for Treatment of Human Infections Caused by Bartonella Species. Antimicrob. Agents Chemother. 2004;48:1921–1933. doi: 10.1128/AAC.48.6.1921-1933.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ives T.J., Manzewitsch P., Regnery R.L., Butts J.D., Kebede M. In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers. Antimicrob. Agents Chemother. 1997;41:578–582. doi: 10.1128/AAC.41.3.578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ives T.J., Marston E.L., Regnery R.L., Butts J.D. In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. Int. J. Antimicrob. Agents. 2001;18:217–222. doi: 10.1016/S0924-8579(01)00388-0. [DOI] [PubMed] [Google Scholar]
  • 20.Ives T.J., Marston E.L., Regnery R.L., Butts J.D., Majerus T.C. In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. J. Antimicrob. Chemother. 2000;45:305–310. doi: 10.1093/jac/45.3.305. [DOI] [PubMed] [Google Scholar]
  • 21.Biswas S., Rolain J.M. Bartonella infection: Treatment and drug resistance. Future Microbiol. 2010;5:1719–1731. doi: 10.2217/fmb.10.133. [DOI] [PubMed] [Google Scholar]
  • 22.Okaro U., George S., Anderson B. What Is in a Cat Scratch? Growth of Bartonella henselae in a Biofilm. Microorganisms. 2021;9:835. doi: 10.3390/microorganisms9040835. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All the available data were reported in the Case presentation.


Articles from Microorganisms are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES